In recent trading session, MEI Pharma Inc (NASDAQ:MEIP) saw 34.04 million shares changing hands at last check today with its beta currently measuring 0.31. Company’s recent per share price level of $6.19 trading at $1.69 or 37.56% at last check today assigns it a market valuation of $41.24M. That most recent trading price of MEIP’s stock is at a premium of 27.3% from its 52-week high price of $4.50 and is indicating a premium of 76.41% from its 52-week low price of $1.46. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 41120.0 shares which gives us an average trading volume of 30.19K if we extend that period to 3-months.

For MEI Pharma Inc (MEIP), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.33. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

MEI Pharma Inc (NASDAQ:MEIP) trade information

MEI Pharma Inc’s shares saw a change of 120.28% in year-to-date performance and have moved 130.11% in past 5-day. MEI Pharma Inc (NASDAQ:MEIP) showed a performance of 175.11% in past 30-days. Number of shares sold short was 1297.0 shares which calculate 0.19 days to cover the short interests.

MEI Pharma Inc (NASDAQ:MEIP)’s Major holders

Insiders are in possession of 1.31% of company’s total shares while institution are holding 40.16 percent of that, with stock having share float percentage of 40.69%. Investors also watch the number of corporate investors in a company very closely, which is 40.16% institutions for MEI Pharma Inc that are currently holding shares of the company.